Search

Your search keyword '"Pirillo, Francesca"' showing total 11 results
Start Over Author "Pirillo, Francesca"
11 results on '"Pirillo, Francesca"'

1. Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib

Author

Caocci, Giovanni, Mulas, Olga, Capodanno, Isabella, Bonifacio, Massimiliano, Annunziata, Mario, Galimberti, Sara, Luciano, Luigiana, Tiribelli, Mario, Martino, Bruno, Castagnetti, Fausto, Binotto, Gianni, Pregno, Patrizia, Stagno, Fabio, Abruzzese, Elisabetta, Bocchia, Monica, Gozzini, Antonella, Albano, Francesco, Fozza, Claudio, Luzi, Debora, Efficace, Fabio, Simula, Maria Pina, Scaffidi, Luigi, Baratè, Claudia, De Gregorio, Fiorenza, Stella, Rossella, Gugliotta, Gabriele, Pirillo, Francesca, Trawinska, Malgorzata Monika, Sicuranza, Anna, Cattaneo, Daniele, Attolico, Immacolata, Scalzulli, Emilia, Iurlo, Alessandra, Foà, Robin, Breccia, Massimo, and La Nasa, Giorgio

Published
2021
Full Text
View/download PDF

2. Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors

Author

Mulas, Olga, Caocci, Giovanni, Stagno, Fabio, Bonifacio, Massimiliano, Annunziata, Mario, Luciano, Luigiana, Orlandi, Ester Maria, Abruzzese, Elisabetta, Sgherza, Nicola, Martino, Bruno, Albano, Francesco, Galimberti, Sara, Pregno, Patrizia, Bocchia, Monica, Castagnetti, Fausto, Tiribelli, Mario, Binotto, Gianni, Gozzini, Antonella, Capodanno, Isabella, Fozza, Claudio, Luzi, Debora, Efficace, Fabio, Simula, Maria Pina, Scaffidi, Luigi, De Gregorio, Fiorenza, Elena, Chiara, Trawinska, Malgorzata Monika, Cattaneo, Daniele, Attolico, Imma, Baratè, Claudia, Pirillo, Francesca, Sicuranza, Anna, Gugliotta, Gabriele, Stella, Rossella, Scalzulli, Emilia, Iurlo, Alessandra, Foà, Robin, Breccia, Massimo, and La Nasa, Giorgio

Published
2020
Full Text
View/download PDF

3. Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

Author

Caocci, Giovanni, Mulas, Olga, Capodanno, Isabella, Abruzzese, Elisabetta, Iurlo, Alessandra, Luciano, Luigiana, Albano, Francesco, Annunziata, Mario, Tiribelli, Mario, Bonifacio, Massimiliano, Galimberti, Sara, Castagnetti, Fausto, Sgherza, Nicola, Stagno, Fabio, Gozzini, Antonella, Orlandi, Ester Maria, Luzi, Debora, Binotto, Gianni, Pregno, Patrizia, Fozza, Claudio, Efficace, Fabio, Simula, Maria Pina, Trawinska, Malgorzata Monika, Cattaneo, Daniele, De Gregorio, Fiorenza, Attolico, Immacolata, Stella, Rossella, Scaffidi, Luigi, Baratè, Claudia, Gugliotta, Gabriele, Scalzulli, Emilia, Elena, Chiara, Pirillo, Francesca, Foà, Robin, Breccia, Massimo, and Nasa, Giorgio La

Published
2020
Full Text
View/download PDF

4. Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors

Author

Caocci, Giovanni, Mulas, Olga, Annunziata, Mario, Luciano, Luigiana, Abruzzese, Elisabetta, Bonifacio, Massimiliano, Orlandi, Ester Maria, Albano, Francesco, Galimberti, Sara, Iurlo, Alessandra, Pregno, Patrizia, Sgherza, Nicola, Martino, Bruno, Binotto, Gianni, Castagnetti, Fausto, Gozzini, Antonella, Bocchia, Monica, Fozza, Claudio, Stagno, Fabio, Simula, Maria Pina, De Gregorio, Fiorenza, Trawinska, Malgorzata Monika, Scaffidi, Luigi, Elena, Chiara, Attolico, Imma, Baratè, Claudia, Cattaneo, Daniele, Pirillo, Francesca, Gugliotta, Gabriele, Sicuranza, Anna, Molica, Matteo, La Nasa, Giorgio, Foà, Robin, and Breccia, Massimo

Published
2020
Full Text
View/download PDF

5. Low Cholesterol, Low-Density Lipoprotein (LDL) and Triglycerides Plasma Levels Are Associated with Lower Risk of Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Nilotinib

Author

Caocci, Giovanni, primary, Mulas, Olga, additional, Capodanno, Isabella, additional, Annunziata, Mario, additional, Abruzzese, Elisabetta, additional, Galimberti, Sara, additional, Tiribelli, Mario, additional, Luciano, Luigiana, additional, Martino, Bruno, additional, Castagnetti, Fausto, additional, Binotto, Gianni, additional, Pregno, Patrizia, additional, Stagno, Fabio, additional, Bocchia, Monica, additional, Albano, Francesco, additional, Luzi, Debora, additional, Fozza, Claudio, additional, Bonifacio, Massimiliano, additional, Elena, Chiara, additional, Gozzini, Antonella, additional, Simula, Maria Pina, additional, Trawinska, Malgorzata Monika, additional, Baratè, Claudia, additional, Stella, Rossella, additional, De Gregorio, Fiorenza, additional, Gugliotta, Gabriele, additional, Pirillo, Francesca, additional, Cattaneo, Daniele, additional, Sicuranza, Anna, additional, Attolico, Imma, additional, Scaffidi, Luigi, additional, Scalzulli, Emilia, additional, Iurlo, Alessandra, additional, Foà, Robin, additional, Breccia, Massimo, additional, and La Nasa, Giorgio, additional

Published
2020
Full Text
View/download PDF

6. Favorable outcome of chronic myeloid leukemia co‐expressing e13a2 and e14a2 transcripts, treated with nilotinib

Author

Mulas, Olga, primary, Caocci, Giovanni, additional, Annunziata, Mario, additional, Martino, Bruno, additional, Luciano, Luigiana, additional, Castagnetti, Fausto, additional, Pregno, Patrizia, additional, Galimberti, Sara, additional, Albano, Francesco, additional, Orlandi, Ester M., additional, Sgherza, Nicola, additional, Iurlo, Alessandra, additional, Bonifacio, Massimiliano, additional, Binotto, Gianni, additional, Gozzini, Antonella, additional, Bocchia, Monica, additional, Abruzzese, Elisabetta, additional, Fozza, Claudio, additional, Simula, Maria P., additional, De Gregorio, Fiorenza, additional, Gugliotta, Gabriele, additional, Pirillo, Francesca, additional, Baratè, Claudia, additional, Attolico, Imma, additional, Elena, Chiara, additional, Cattaneo, Daniele, additional, Scaffidi, Luigi, additional, Sicuranza, Anna, additional, Trawinska, Malgorzata M., additional, Scalzulli, Emilia, additional, Foà, Robin, additional, Breccia, Massimo, additional, and La Nasa, Giorgio, additional

Published
2020
Full Text
View/download PDF

7. Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

Author

Caocci, Giovanni, primary, Mulas, Olga, additional, Abruzzese, Elisabetta, additional, Luciano, Luigiana, additional, Iurlo, Alessandra, additional, Attolico, Immacolata, additional, Castagnetti, Fausto, additional, Galimberti, Sara, additional, Sgherza, Nicola, additional, Bonifacio, Massimiliano, additional, Annunziata, Mario, additional, Gozzini, Antonella, additional, Orlandi, Ester Maria, additional, Stagno, Fabio, additional, Binotto, Gianni, additional, Pregno, Patrizia, additional, Fozza, Claudio, additional, Trawinska, Malgorzata Monika, additional, De Gregorio, Fiorenza, additional, Cattaneo, Daniele, additional, Albano, Francesco, additional, Gugliotta, Gabriele, additional, Baratè, Claudia, additional, Scaffidi, Luigi, additional, Elena, Chiara, additional, Pirillo, Francesca, additional, Scalzulli, Emilia, additional, La Nasa, Giorgio, additional, Foà, Robin, additional, and Breccia, Massimo, additional

Published
2019
Full Text
View/download PDF

8. Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis

Author

Caocci, Giovanni, primary, Mulas, Olga, additional, Annunziata, Mario, additional, Luciano, Luigiana, additional, Bonifacio, Massimiliano, additional, Orlandi, Ester Maria, additional, Pregno, Patrizia, additional, Galimberti, Sara, additional, Russo Rossi, Antonella, additional, Abruzzese, Elisabetta, additional, Iurlo, Alessandra, additional, Martino, Bruno, additional, Sgherza, Nicola, additional, Binotto, Gianni, additional, Castagnetti, Fausto, additional, Gozzini, Antonella, additional, Fozza, Claudio, additional, Bocchia, Monica, additional, Sicuranza, Anna, additional, Stagno, Fabio, additional, Efficace, Fabio, additional, Usala, Emilio, additional, De Gregorio, Fiorenza, additional, Scaffidi, Luigi, additional, Elena, Chiara, additional, Pirillo, Francesca, additional, Baratè, Claudia, additional, Trawinska, Malgorzata Monika, additional, Cattaneo, Daniele, additional, Labate, Claudia, additional, Gugliotta, Gabriele, additional, Molica, Matteo, additional, Specchia, Giorgina, additional, La Nasa, Giorgio, additional, Foà, Robin, additional, and Breccia, Massimo, additional

Published
2018
Full Text
View/download PDF

9. A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib

Author

Ferrero, Dario, primary, Crisà, Elena, additional, Cerrano, Marco, additional, Boccadoro, Mario, additional, Pirillo, Francesca, additional, Nicolosi, Maura, additional, Vitolo, Umberto, additional, Cambrin, Giovanna Rege, additional, Fava, Carmen, additional, Saglio, Giuseppe, additional, Lunghi, Monia, additional, Catania, Gioacchino, additional, Levis, Alessandro, additional, and Pregno, Patrizia, additional

Published
2012
Full Text
View/download PDF

10. The Dose and the duration of frontline therapy with Imatinib does not affect response to Dasatinib in Imatinib-Resistant or -intolerant patients with chronic myeloid leukemia (CML). Results from a real Life-Based Italian Multicenter retrospective study on 124 Patients.

Author

Visani, Giuseppe, primary, Breccia, Massimo, additional, Piccaluga, Pier Paolo, additional, Gozzini, Antonella, additional, Specchia, Giorgina, additional, Montefusco, Enrico, additional, Morra, Enrica, additional, Annunziata, Mario, additional, Luciano, Luigiana, additional, Camera, Andrea, additional, Cavazzini, Francesco, additional, Stagno, Fabio, additional, Di Raimondo, Francesco, additional, Pregno, Patrizia, additional, Pirillo, Francesca, additional, Santini, Valeria, additional, Bosi, Alberto, additional, Pacilli, Matteo, additional, Pungolino, Ester, additional, Usala, Emilio, additional, Angelucci, Emanuele, additional, Crugnola, Monica, additional, Binotto, Gianni, additional, Maino, Elena, additional, Loscocco, Federica, additional, Barulli, Sara, additional, Nicolini, Giuseppina, additional, Cuneo, Antonio, additional, Latagliata, Roberto, additional, Ferrara, Felicetto, additional, and Isidori, Alessandro, additional

Published
2009
Full Text
View/download PDF

11. Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis

Author

Bruno Martino, Robin Foà, Massimo Breccia, Daniele Cattaneo, Francesca Pirillo, Antonella Gozzini, Nicola Sgherza, Alessandra Iurlo, Luigi Scaffidi, Monica Bocchia, Fabio Stagno, Claudio Fozza, Patrizia Pregno, Antonella Russo Rossi, Fabio Efficace, Gabriele Gugliotta, Sara Galimberti, Fausto Castagnetti, Luigiana Luciano, Giorgina Specchia, Massimiliano Bonifacio, Malgorzata Monika Trawinska, Elisabetta Abruzzese, Mario Annunziata, Giovanni Caocci, Ester Orlandi, Chiara Elena, Fiorenza De Gregorio, Anna Sicuranza, Emilio Usala, Claudia Baratè, Matteo Molica, Claudia Labate, Giorgio La Nasa, Gianni Binotto, Olga Mulas, Caocci, Giovanni, Mulas, Olga, Annunziata, Mario, Luciano, Luigiana, Bonifacio, Massimiliano, Orlandi, Ester Maria, Pregno, Patrizia, Galimberti, Sara, Russo Rossi, Antonella, Abruzzese, Elisabetta, Iurlo, Alessandra, Martino, Bruno, Sgherza, Nicola, Binotto, Gianni, Castagnetti, Fausto, Gozzini, Antonella, Fozza, Claudio, Bocchia, Monica, Sicuranza, Anna, Stagno, Fabio, Efficace, Fabio, Usala, Emilio, De Gregorio, Fiorenza, Scaffidi, Luigi, Elena, Chiara, Pirillo, Francesca, Baratè, Claudia, Trawinska, Malgorzata Monika, Cattaneo, Daniele, Labate, Claudia, Gugliotta, Gabriele, Molica, Matteo, Specchia, Giorgina, La Nasa, Giorgio, Foà, Robin, and Breccia, Massimo

Subjects
Oncology, Adult, Male, medicine.medical_specialty, Adolescent, 030204 cardiovascular system & hematology, Risk Assessment, 03 medical and health sciences, Myelogenous, Young Adult, 0302 clinical medicine, Risk Factors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, medicine, 80 and over, Humans, Young adult, Chronic, Protein Kinase Inhibitors, Aged, Aged, 80 and over, Cardiotoxicity, Hematology, Leukemia, business.industry, Myeloid leukemia, Middle Aged, Protein-Tyrosine Kinases, medicine.disease, Italy, 030220 oncology & carcinogenesis, Female, BCR-ABL Positive, Risk assessment, business, Tyrosine kinase
Abstract

NA

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results